1. Home
  2. GCT vs PHAT Comparison

GCT vs PHAT Comparison

Compare GCT & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCT
  • PHAT
  • Stock Information
  • Founded
  • GCT 2019
  • PHAT 2018
  • Country
  • GCT United States
  • PHAT United States
  • Employees
  • GCT N/A
  • PHAT N/A
  • Industry
  • GCT Catalog/Specialty Distribution
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GCT Consumer Discretionary
  • PHAT Health Care
  • Exchange
  • GCT Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • GCT 1.0B
  • PHAT 942.6M
  • IPO Year
  • GCT 2022
  • PHAT 2019
  • Fundamental
  • Price
  • GCT $32.26
  • PHAT $14.85
  • Analyst Decision
  • GCT Buy
  • PHAT Strong Buy
  • Analyst Count
  • GCT 2
  • PHAT 5
  • Target Price
  • GCT $24.00
  • PHAT $17.60
  • AVG Volume (30 Days)
  • GCT 831.6K
  • PHAT 983.2K
  • Earning Date
  • GCT 11-06-2025
  • PHAT 10-30-2025
  • Dividend Yield
  • GCT N/A
  • PHAT N/A
  • EPS Growth
  • GCT 4.32
  • PHAT N/A
  • EPS
  • GCT 3.31
  • PHAT N/A
  • Revenue
  • GCT $1,222,932,000.00
  • PHAT $147,190,000.00
  • Revenue This Year
  • GCT $4.65
  • PHAT $218.38
  • Revenue Next Year
  • GCT $4.94
  • PHAT $87.14
  • P/E Ratio
  • GCT $9.68
  • PHAT N/A
  • Revenue Growth
  • GCT 10.17
  • PHAT 460.30
  • 52 Week Low
  • GCT $11.17
  • PHAT $2.21
  • 52 Week High
  • GCT $34.50
  • PHAT $16.08
  • Technical
  • Relative Strength Index (RSI)
  • GCT 58.01
  • PHAT 64.62
  • Support Level
  • GCT $28.80
  • PHAT $14.12
  • Resistance Level
  • GCT $33.45
  • PHAT $15.28
  • Average True Range (ATR)
  • GCT 1.97
  • PHAT 0.93
  • MACD
  • GCT 0.23
  • PHAT 0.07
  • Stochastic Oscillator
  • GCT 72.54
  • PHAT 82.58

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: